Abstract:Rationale, aims, and objectives: Time to the occurrence of an event is often studied in health research. Survival analysis differs from other designs in that follow-up times for individuals who do not experience the event by the end of the study (called censored) are accounted for in the analysis. Cox regression is the standard method for analysing censored data, but the assumptions required of these models are easily violated. In this paper, we introduce classification tree analysis (CTA) as a flexible alternative for modelling censored data. Classification tree analysis is a "decision-tree"-like classification model that provides parsimonious, transparent (ie, easy to visually display and interpret) decision rules that maximize predictive accuracy, derives exact P values via permutation tests, and evaluates model cross-generalizability. Method: Using empirical data, we identify all statistically valid, reproducible, longitudinally consistent, and cross-generalizable CTA survival models and then compare their predictive accuracy to estimates derived via Cox regression and an unadjusted naïve model. Model performance is assessed using integrated Brier scores and a comparison between estimated survival curves. Results: The Cox regression model best predicts average incidence of the outcome over time, whereas CTA survival models best predict either relatively high, or low, incidence of the outcome over time. Conclusions: Classification tree analysis survival models offer many advantages over Cox regression, such as explicit maximization of predictive accuracy, parsimony, statistical robustness, and transparency. Therefore, researchers interested in accurate prognoses and clear decision rules should consider developing models using the CTA-survival framework.

Core Concepts in Pharmacoepidemiology: Time‐To‐Event Analysis Approaches in Pharmacoepidemiology

Methods to Analyse Time-to-Event Data: The Kaplan-Meier Survival Curve

Analysis of time-to-event for observational studies: Guidance to the use of intensity models

Survival Analysis and Interpretation of Time-to-Event Data: The Tortoise and the Hare

Methods to Analyze Time-to-Event Data: The Cox Regression Analysis

Alternative Analysis Methods for Time to Event Endpoints under Non-proportional Hazards: A Comparative Analysis

Alternative Analysis Methods for Time to Event Endpoints Under Nonproportional Hazards: A Comparative Analysis

Time-to-event estimands and loss to follow-up in oncology in light of the estimands framework

Bayesian Dose Finding by Jointly Modelling Toxicity and Efficacy As Time-To-Event Outcomes

Treatment Effect Quantification for Time-to-event Endpoints -- Estimands, Analysis Strategies, and beyond

Modeling time-to-event (survival) data using classification tree analysis

Time‐to‐event estimands and loss to follow‐up in oncology in light of the estimands guidance

Statistical approaches for component-wise censored composite endpoints

Left-censored recurrent event analysis in epidemiological studies: a proposal when the number of previous episodes is unknown

Understanding the Impact of Competing Events on Heterogeneous Treatment Effect Estimation from Time-to-Event Data

Statistical Considerations for Evaluating Treatment Effect under Various Non-proportional Hazard Scenarios

Practical methods for incorporating summary time-to-event data into meta-analysis

Analysis of composite time-to-event endpoints in cardiovascular outcome trials

The Clone-Censor-Weight Method in Pharmacoepidemiologic Research: Foundations and Methodological Implementation

Inference for Cumulative Incidences and Treatment Effects in Randomized Controlled Trials with Time-to-Event Outcomes under ICH E9 (R1)